Skip to content
ASP Isotopes, Inc. logo

ASP Isotopes, Inc.

ASPI

ASP Isotopes Inc. is an advanced materials company that develops and operates proprietary isotope enrichment technologies, specifically the Aerodynamic Separation Process (ASP) and Quantum Enrichment (QE) platforms.

Market cap
$647.77M+3.8%
Revenue$26.9M+511%
Net income-$158.5M-367%
Free cash flow-$65.9M-138%
EPS (diluted)-$2.08-241%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 14, 2026 (in a month)
Revenue estimate$4.5M
EPS estimate-$0.17

Financials

Q1 2026

Income statement

See full
Revenue$4.2M+279%
Gross profit$1.7M+409%
Operating income-$24.9M-213%
Net income-$7.1M+15.8%
EPS (diluted)-$0.06+50.0%

Balance sheet

See full
Cash & equivalents$211.7M+278%
Total debt$61.9M+1,787%
Total equity$289.0M+580%
Total assets$587.7M+547%

Cash flow

See full
Operating cash flow-$17.8M-460%
CapEx$6.1M+166%
Free cash flow-$23.9M-336%

Valuation & ratios

Valuation

See full
Market cap$647.77M+3.8%
Enterprise value$497.98M-5.9%
P/S24.1×-106×

Profitability

See full
Gross margin17.6%-19.8pp
Operating margin-285.4%-102pp
Net margin-588.6%-112pp
FCF margin-244.6%-92.7pp

Returns & leverage

See full
Return on equity-95.6%-19.3pp
Debt / equity0.2×+0.1×
Current ratio4.4×-2.8×

Segments

By geography

See full
ZA$2.6M+140%
US$1.5M

By product

See full
Collaboration Revenue$200.0K

Competitors

Profile

ASP Isotopes Inc. is an advanced materials company that develops and operates proprietary isotope enrichment technologies, specifically the Aerodynamic Separation Process (ASP) and Quantum Enrichment (QE) platforms. The company focuses on producing high-value isotopes for use in nuclear medicine, next-generation semiconductors, and carbon-free nuclear energy. Through strategic acquisitions, the company has also expanded into natural gas exploration and the production of liquid helium and liquefied natural gas (LNG).

Competitive position

The company holds a unique position as a developer of proprietary aerodynamic and laser-based enrichment technologies with a first-mover advantage in South African onshore helium production.

GeographiesSouth Africa, United States, Iceland, United Kingdom, Hong Kong
Customer segmentsHealthcare, Technology, Energy, Government
Business modelManufacturing, Resource Extraction, Licensing, EPC Services
SuppliersNatural gas reserves, Raw isotope feedstocks, Nuclear research facilities, Specialized engineering components
CustomersRadiopharmaceutical manufacturers, Semiconductor foundries, Nuclear power plant operators, Industrial gas consumers
Listed2022
Employees76.0
CEOPaul Elliot Mann
IndustryChemicals
FilingsSEC EDGAR

Questions, answered.

What is ASP Isotopes, Inc.'s market cap?
ASP Isotopes, Inc. (ASPI) has a market capitalization of $647.8M and trades on NASDAQ.
What is ASP Isotopes, Inc.'s revenue and profitability?
ASP Isotopes, Inc. generated $26.9M in trailing twelve-month revenue with a net loss of $158.5M, representing a net margin of -588.6%. Gross margin stands at 17.6%, with free cash flow of -$65.9M. These figures are based on the Q1 2026 filing.
Who are ASP Isotopes, Inc.'s competitors?
ASP Isotopes, Inc.'s key competitors include Air Products and Chemicals, Inc., Centrus Energy Corp., Metallus Inc., and others. These companies compete in similar markets and product categories.
Who does ASP Isotopes, Inc. partner with?
ASP Isotopes, Inc.'s notable partners include TerraPower, LLC, The South African Nuclear Energy Corporation (Necsa).
What subsidiaries does ASP Isotopes, Inc. have?
ASP Isotopes, Inc.'s subsidiaries include Quantum Leap Energy, LLC, Renergen Limited, Tetra4 Proprietary Limited, and others.
Where is ASP Isotopes, Inc. headquartered?
ASP Isotopes, Inc. is headquartered in United States of America and employs approximately 76 people. It has been publicly traded since 2022.